The US Hemp Roundtable (USHR) responded to

Dear Chairs and Ranking Members, 

We are writing to share our concerns about a recent review article authored by FDA staff entitled “Review of the Oral Toxicity of Cannabidiol (CBD)The article claims to be a summary of the data and 1 information in the scientific literature regarding toxicological concerns associated with CBD consumption, and purports to provide a “thorough toxicological hazard identification.” It concludes the “data clearly establish CBD’s potential for adverse health effects when consumed without medical supervision by the general population”…